| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.75▲ | 3.76▼ | 3.79▼ | 4.13▼ | 2.72▲ |
| MA10 | 3.73▲ | 3.79▼ | 3.89▼ | 3.60▲ | 2.20▲ |
| MA20 | 3.76▼ | 3.91▼ | 4.10▼ | 2.83▲ | 2.99▲ |
| MA50 | 3.80▼ | 4.07▼ | 3.83▼ | 2.21▲ | 10.09▼ |
| MA100 | 4.03▼ | 3.70▲ | 3.28▲ | 3.16▲ | 18.39▼ |
| MA200 | 4.08▼ | 3.09▲ | 2.48▲ | 8.62▼ | 33.87▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.005▲ | -0.012▼ | -0.072▼ | 0.142▲ | 0.689▲ |
| RSI | 47.001▼ | 38.659▼ | 41.582▼ | 61.636▲ | 42.993▼ |
| STOCH | 44.710 | 29.870 | 18.524▼ | 79.299 | 44.171 |
| WILL %R | -62.500 | -85.714▼ | -90.551▼ | -33.805 | -30.891 |
| CCI | 18.482 | -78.033 | -86.851 | 53.493 | 123.724▲ |
|
Saturday, August 23, 2025 05:03 AM
The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you ...
|
|
Thursday, April 24, 2025 05:15 AM
(Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that it will report financial results for the first quarter ended March 31 ...
|
|
Sunday, March 23, 2025 02:06 PM
$XFOR Hedge Fund Activity We have seen 34 institutional investors add shares of $XFOR stock to their portfolio, and 53 decrease their positions in their most recent quarter.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 29/08/25 | 4.01 | 4.09 | 3.70 | 3.755 | 897,700 |
| 28/08/25 | 4.335 | 4.367 | 4.01 | 4.12 | 591,300 |
| 27/08/25 | 4.51 | 4.83 | 4.22 | 4.23 | 1,364,500 |
| 26/08/25 | 3.97 | 4.65 | 3.57 | 4.58 | 1,970,400 |
| 25/08/25 | 3.81 | 4.36 | 3.81 | 3.97 | 1,873,600 |
| 22/08/25 | 3.15 | 3.929 | 3.12 | 3.92 | 3,259,600 |
| 21/08/25 | 2.82 | 3.21 | 2.71 | 3.18 | 1,627,500 |
| 20/08/25 | 2.90 | 3.00 | 2.69 | 2.80 | 1,727,559 |
| 19/08/25 | 2.58 | 3.42 | 2.45 | 2.93 | 9,334,100 |
| 18/08/25 | 2.82 | 3.22 | 2.49 | 2.49 | 2,767,800 |
|
|
||||
|
|
||||
|
|